D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 66 Citations 14,590 238 World Ranking 3751 National Ranking 1894

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Internal medicine
  • Gene

Vladimir R. Muzykantov mainly investigates Endothelium, Drug delivery, Pharmacology, Nanocarriers and Biochemistry. His Endothelium research includes elements of Oxidative stress, Inflammation, Endocytosis and ICAM-1, Cell adhesion molecule. His studies deal with areas such as Ex vivo, Neoplasms diagnosis and Rational design as well as Drug delivery.

His Pharmacology research is multidisciplinary, incorporating elements of Plasminogen activator, Lung, Immunology and Pathology. His study in Nanocarriers is interdisciplinary in nature, drawing from both Intercellular Adhesion Molecule-1, Biophysics and Liposome. In his research on the topic of Biochemistry, NADPH oxidase and Streptavidin is strongly related with Molecular biology.

His most cited work include:

  • Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities (904 citations)
  • Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. (425 citations)
  • A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 (268 citations)

What are the main themes of his work throughout his whole career to date?

Pharmacology, Endothelium, Biochemistry, Drug delivery and Molecular biology are his primary areas of study. His Pharmacology research includes themes of Plasminogen activator and Immunology, Fibrin. The concepts of his Endothelium study are interwoven with issues in Endothelial stem cell, Oxidative stress, Inflammation and Cell adhesion molecule, Cell biology.

When carried out as part of a general Biochemistry research project, his work on Biotinylation, Biotin, Enzyme and Superoxide dismutase is frequently linked to work in Conjugate, therefore connecting diverse disciplines of study. His Drug delivery study combines topics from a wide range of disciplines, such as Liposome and Drug. He has researched Molecular biology in several fields, including In vitro, Epitope, Antibody, Monoclonal antibody and Thrombin.

He most often published in these fields:

  • Pharmacology (25.14%)
  • Endothelium (24.86%)
  • Biochemistry (20.86%)

What were the highlights of his more recent work (between 2013-2021)?

  • Drug delivery (18.86%)
  • Nanocarriers (17.43%)
  • Pharmacology (25.14%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Drug delivery, Nanocarriers, Pharmacology, Inflammation and Targeted drug delivery. His research on Drug delivery focuses in particular on Drug carrier. His Nanocarriers research is multidisciplinary, incorporating perspectives in Biophysics, Ferritin, Cell adhesion molecule, Cell biology and Nanomedicine.

His work deals with themes such as Immunology, Sepsis, Thrombin and Biodistribution, which intersect with Pharmacology. His Inflammation research incorporates themes from Oxidative stress, Superoxide dismutase, Pathology, Endothelium and Lung injury. His Targeted drug delivery research integrates issues from Adhesion, ICAM-1, Primary Graft Dysfunction, Biochemistry and Nanogel.

Between 2013 and 2021, his most popular works were:

  • Targeting vascular (endothelial) dysfunction (206 citations)
  • Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. (137 citations)
  • European contribution to the study of ROS : a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (132 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Internal medicine
  • Gene

His primary areas of investigation include Drug delivery, Nanocarriers, Pharmacology, Drug carrier and Inflammation. His Drug delivery study focuses on Targeted drug delivery in particular. His work in Pharmacology tackles topics such as Cell adhesion molecule which are related to areas like Endothelial stem cell, Intracellular and Apolipoprotein E.

Vladimir R. Muzykantov has included themes like Oxidative stress, Superoxide dismutase, Reactive oxygen species, Endothelium and Lung injury in his Inflammation study. His Oxidative stress study combines topics in areas such as Disease progression, Biophysics, Oxidation reduction and Immunology. His Endothelium study incorporates themes from Adipose tissue, Pathology and Circulatory system, Cardiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities

Zhiliang Cheng;Ajlan Al Zaki;James Z. Hui;Vladimir R. Muzykantov.
Science (2012)

1138 Citations

Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.

Silvia Muro;Carmen Garnacho;Julie A Champion;John Leferovich.
Molecular Therapy (2008)

514 Citations

Endothelial NADPH Oxidase as the Source of Oxidants in Lungs Exposed to Ischemia or High K

Abu B. Al-Mehdi;Guochang Zhao;Chandra Dodia;Kasumi Tozawa.
Circulation Research (1998)

388 Citations

Drug delivery by red blood cells: vascular carriers designed by mother nature

Vladimir R. Muzykantov.
Expert Opinion on Drug Delivery (2010)

347 Citations

A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1

Silvia Muro;Rainer Wiewrodt;Anu Thomas;Lauren Koniaris.
Journal of Cell Science (2003)

338 Citations

Targeting vascular (endothelial) dysfunction

Andreas Daiber;Sebastian Steven;Alina Weber;Vladimir V. Shuvaev.
British Journal of Pharmacology (2017)

280 Citations

1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage.

Yefim Manevich;Tom Sweitzer;Jhang Ho Pak;Sheldon I. Feinstein.
Proceedings of the National Academy of Sciences of the United States of America (2002)

268 Citations

Targeting of superoxide dismutase and catalase to vascular endothelium.

Vladimir R Muzykantov.
Journal of Controlled Release (2001)

247 Citations

Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species.

Caryn Vadseth;Jose M. Souza;Leonor Thomson;Amy Seagraves.
Journal of Biological Chemistry (2004)

243 Citations

Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1

Silvia Muro;Thomas Dziubla;Weining Qiu;John Leferovich.
Journal of Pharmacology and Experimental Therapeutics (2006)

211 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Vladimir R. Muzykantov

Aron B. Fisher

Aron B. Fisher

University of Pennsylvania

Publications: 68

Thomas Münzel

Thomas Münzel

Johannes Gutenberg University of Mainz

Publications: 36

Mauro Ferrari

Mauro Ferrari

Houston Methodist

Publications: 32

Vladimir P. Torchilin

Vladimir P. Torchilin

Northeastern University

Publications: 31

Andreas Daiber

Andreas Daiber

Johannes Gutenberg University of Mainz

Publications: 27

Douglas B. Cines

Douglas B. Cines

University of Pennsylvania

Publications: 26

Yefim Manevich

Yefim Manevich

Medical University of South Carolina

Publications: 25

Paolo Decuzzi

Paolo Decuzzi

Italian Institute of Technology

Publications: 24

Alexander V. Kabanov

Alexander V. Kabanov

University of North Carolina at Chapel Hill

Publications: 22

Mauro Magnani

Mauro Magnani

University of Urbino

Publications: 20

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 19

Thomas P. Davis

Thomas P. Davis

University of Queensland

Publications: 17

Harry Ischiropoulos

Harry Ischiropoulos

Children's Hospital of Philadelphia

Publications: 16

Karlheinz Peter

Karlheinz Peter

Baker IDI Heart and Diabetes Institute

Publications: 16

Frank Caruso

Frank Caruso

University of Melbourne

Publications: 14

Zhen Gu

Zhen Gu

Zhejiang University

Publications: 14

Something went wrong. Please try again later.